Hyrimoz 20 mg (Adalimumab SOLUTION) 20 MG

HYRIMOZ 20 MG is a subcutaneous solution containing adalimumab, used for managing inflammatory conditions. This medication is designed to help reduce symptoms and improve quality of life for those with chronic conditions.

Strength

20 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HYRIMOZ 20 MG is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by targeting specific proteins in the body to reduce inflammation and alleviate symptoms. People often ask, 'What is HYRIMOZ used for?' and the answer lies in its ability to manage chronic inflammatory diseases effectively.

Side Effects

Common effects of HYRIMOZ 20 MG may include injection site reactions, such as redness, swelling, or itching. Some users might experience fatigue, nausea, or mild headaches. These effects are generally mild and temporary, but it's important to monitor any persistent or severe reactions.

Precautions & Warnings

HYRIMOZ 20 MG should be handled with care, ensuring proper storage and administration as directed. It is important to inform healthcare providers about any existing medical conditions or allergies before starting treatment. Always follow the prescribed guidelines for subcutaneous administration to minimize risks.

Avoid Interactions

HYRIMOZ 20 MG may interact with certain medications, including those that affect the immune system. It is advisable to consult with a healthcare provider before combining it with other treatments. Alcohol and certain supplements might also influence its effectiveness or safety.

Frequently Asked Questions

HYRIMOZ 20 MG is used to manage inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

HYRIMOZ 20 MG is administered subcutaneously, typically through an injection.

Common side effects may include injection site reactions, fatigue, nausea, and mild headaches.

It is important to consult with a healthcare provider before combining HYRIMOZ 20 MG with other medications.

HYRIMOZ 20 MG should be stored as directed, typically in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.